FRANCESCO BORRELLI,MAURO D'ANTONIO,FABRIZIO MARTELLI
申请号：
EEP200100378
公开号：
EE05543B1
申请日:
2000.01.19
申请国别(地区):
EE
年份:
2012
代理人:
摘要：
Tumor necrosis factor antagonists are administered in therapeutically effective doses to treat and/or prevent endometriosis. The antagonists of this invention typically are selected from among several classes but preferably are soluble TNF receptors. The antagonists are useful for the regression of endometriotic lesions and, if combined with other active ingredients, for amelioration of related disorders, like infertility.
